Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
48.10    -1.10 (-2.24%)
Bid:
48.35
Ask:
48.60
Spread: 0.25 (0.517%)
Market Cap: £304.41m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Result of Rights Issue

22 Jul 2009 07:00

RNS Number : 0580W
Marston's PLC
22 July 2009
Ā 



THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

22Ā July 2009

Marston'sĀ PLCĀ ("Marston's" or "the Company")

Result of Rights Issue

Marston'sĀ announces thatĀ it hasĀ received valid acceptances in respect ofĀ 273,269,134Ā New Shares, representing approximatelyĀ 91.44%Ā of the total number of New Shares offered toĀ QualifyingĀ Shareholders, pursuant to the Rights Issue announced by the Company onĀ 18Ā JuneĀ 2009.

Ā 

It is expected that the New Shares in uncertificated form will be credited to CREST accounts onĀ 22 JulyĀ 2009 and that definitive share certificates in respect of New Shares in certificated form will be dispatched by no later thanĀ 31 JulyĀ 2009.Ā It is expected that the New Shares will commence trading fully paid onĀ the London Stock Exchange'sĀ main market for listed securities onĀ 22 JulyĀ 2009.

As disclosed in PartsĀ IIIĀ and VIIĀ of theĀ prospectus sent toĀ Shareholders dated 18 JuneĀ 2009 ("Prospectus"),Ā RBS Hoare Govett and J.P. MorganĀ Cazenove, acting as Joint Bookrunners,Ā will endeavour to procure subscribers for the balance ofĀ 25,596,096Ā New Shares not validly taken up under the Rights Issue,Ā on andĀ subject toĀ theĀ terms and conditions agreed with the CompanyĀ underĀ the Underwriting Agreement. A further announcement as to the number of New Shares for which subscribers have beenĀ soĀ procured will be made in due course.

Unless otherwise defined in this announcement, capitalised terms shall have the meaning given to them in the Prospectus.

Contacts

For further information please contact:

Marston'sĀ PLC:

+44 (0)1902 711 811

Ralph Findlay, Chief Executive

Andrew Andrea, Finance Director

Rothschild:

+44 (0)20 7280 5000

Crispin Wright

Adam Young

RBS Hoare Govett:

+44 (0)20 7678 8000Ā 

Sara Hale

Jonathan Retter

Jeremy ThompsonĀ 

J.P. Morgan Cazenove:

+44 (0)20 7588 2828

Laurence Hollingworth

James Mitford

Neil Haycock

HudsonĀ Sandler:

+44(0)20 7796 4133

Andrew Hayes

Nick Lyon

James White

DISCLAIMER

This announcement does not constitute or form part of any offer or invitation to purchase, otherwise acquire, subscribe for, sell, otherwise dispose of or issue, or any solicitation of any offer to sell, otherwise dispose of, issue, purchase, otherwise acquire or subscribe for, any security.

This announcement is an advertisement and does not constitute a prospectus or prospectus equivalent document. Nothing in this announcement should be interpreted as a term or condition of the Rights Issue. Any decision to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any Provisional Allotment Letter, Nil Paid Rights, Fully Paid Rights, and/or New Shares must be made only on the basis of the information contained in and incorporated by reference into the Prospectus. Copies of the ProspectusĀ areĀ availableĀ atĀ the Company'sĀ registered office.

RBS Hoare Govett,Ā J.P. Morgan CazenoveĀ and Rothschild, which are regulated in the United Kingdom by the Financial Services Authority, are acting exclusively for the Company and for no-one else in relation to the Rights Issue and will not be responsible to anyone other than the Company for providing the protections afforded to their respective customers or for providing advice in relation to the Rights Issue or the contents of this announcement or any of the other matters referred to in this announcement.

The New Shares, the Nil Paid Rights, the Fully Paid Rights and the Provisional Allotment Letters have not been and will not be registered under the US Securities Act of 1933, as amended (theĀ USĀ Securities Act) and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, in the United States absent registration or pursuant to an exemption from, or in transactions not subject to, the registration requirements of the US Securities Act.

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
ROIBFLLLKDBBBBE
Date   Source Headline
1st Jun 20262:38 pmRNSTotal Voting Rights
19th May 202611:12 amRNSDirector Declaration
12th May 20267:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 28 MARCH 2026
1st Apr 20263:12 pmRNSTotal Voting Rights
2nd Mar 202611:43 amRNSTotal Voting Rights
23rd Feb 20265:33 pmRNSHolding(s) in Company
11th Feb 202611:21 amRNSDirector/PDMR Shareholding
2nd Feb 20263:28 pmRNSTotal Voting Rights
28th Jan 202612:37 pmRNSResult of AGM
28th Jan 20267:00 amRNSTrading update for the 17 weeks to 24 January 2026
12th Jan 20262:00 pmRNSBlock listing Interim Review
9th Jan 20269:30 amRNSPurchase of shares into the EBT
2nd Jan 20262:55 pmRNSTotal Voting Rights
29th Dec 202510:46 amRNSDirector/PDMR Shareholding
29th Dec 202510:46 amRNSDirector/PDMR Shareholding
29th Dec 202510:44 amRNSDirector/PDMR Shareholding
29th Dec 202510:44 amRNSDirector/PDMR Shareholding
12th Dec 202511:07 amRNSAnnual Financial Report
11th Dec 20259:54 amRNSPurchase of shares into the EBT
1st Dec 20254:15 pmRNSTotal Voting Rights
28th Nov 202512:36 pmRNSDirector/PDMR Shareholding
28th Nov 202512:30 pmRNSDirector/PDMR Shareholding
25th Nov 20257:00 amRNSPRELIMINARY RESULTS
28th Oct 20254:54 pmRNSHolding(s) in Company
8th Oct 20257:00 amRNSTrading Update for 52 weeks to 27 September 2025
1st Oct 20254:16 pmRNSTotal Voting Rights
1st Sep 20253:22 pmRNSTotal Voting Rights
1st Aug 20254:17 pmRNSTotal Voting Rights
22nd Jul 20257:00 amRNSTrading Update for the 41 weeks to 12 July 2025
9th Jul 20252:35 pmRNSBlock listing Interim Review
1st Jul 20255:03 pmRNSTotal Voting Rights
26th Jun 20257:05 amRNSAppointment of Chief Financial Officer
13th May 20257:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 29 MARCH 2025
1st May 20253:04 pmRNSTotal Voting Rights
1st Apr 20251:40 pmRNSTotal Voting Rights
20th Mar 202512:48 pmRNSPurchase of shares into the EBT
17th Mar 20251:10 pmRNSPurchase of shares into the EBT
4th Mar 20257:00 amRNSDirectorate Change
25th Feb 20259:24 amRNSHolding(s) in Company
21st Jan 20253:21 pmRNSResult of AGM
21st Jan 20257:00 amRNSTrading Update for the 16 weeks to 18 January 2025
13th Jan 20253:36 pmRNSPurchase of shares into the EBT
10th Jan 202510:13 amRNSBlock listing Interim Review
8th Jan 202511:55 amRNSHolding(s) in Company
2nd Jan 202511:27 amRNSTotal Voting Rights
23rd Dec 202412:15 pmRNSDirector/PDMR Shareholding
20th Dec 202410:47 amRNSPurchase of shares into the EBT
17th Dec 20244:22 pmRNSAnnual Financial Report
12th Dec 20242:59 pmRNSDirector/PDMR Shareholding
6th Dec 20249:51 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.